Home News ‘90–95% Effective’: Top US Health Expert Vouches for Pfizer Coronavirus Vaccine’s Efficacy

‘90–95% Effective’: Top US Health Expert Vouches for Pfizer Coronavirus Vaccine’s Efficacy

‘90–95% Effective’: Top US Health Expert Vouches for Pfizer Coronavirus Vaccine’s Efficacy

American physician and immunologist Anthony Fauci has said that Pfizer’s coronavirus vaccine, which has been developed in collaboration with Germany’s BioNTech SE, has an extraordinarily high degree of efficacy. “More than 90 percent, close to 95 percent,” Fauci said during an interview, adding that this would lead to a turnaround in general skepticism about vaccines that have been developed at top speed.

“What I would hope is that even though there’s a degree of skepticism about vaccines in general, that when the general public sees how effective this vaccine is,” said Fauci, who’s the head of the National Institute of Allergy and Infectious Diseases.

As per Fauci, the vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week.

The US administration has funded the company for the development of Pfizer vaccine. The country has also secured the advanced purchase of the vaccine and aims to cover the entire US population with the COVID-19 vaccine by the year-end.

Pfizer and BioNTech on November 9 said that their COVID-19 vaccine candidate was found to be more than 90 percent effective in preventing COVID-19. The trial’s result was based on the first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study. The COVID-19 vaccine, BNT162b2, being developed by Pfizer Inc. and BioNTech is in the late-stage vaccine trial.

While Pfizer became the first company to release successful data from a large-scale trial, India’s best bets are still the homegrown Covaxin by Bharat Biotech and the home-tested AstraZeneca-Oxford University vaccine. These two vaccine candidates are in equally advanced stages of Phase 3 trials. Unlike Pfizer, these two vaccine candidates are undergoing trials in India and will be available to the masses in the country as soon as tests are completed.

Besides, Russia’s Sputnik V vaccine, which is the world’s first coronavirus vaccine, is also touted to be 92 percent effective against coronavirus, the Russian government has claimed.

US-based Moderna Inc, which is developing its vaccine based on mRNA technology (similar to Pfizer), has said that it will release the data on its advanced-stage trials of its COVID-19 vaccine candidate by the month-end. As per the company, it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation’s efficacy.

Eskalera, a Startup Led by Goldman Sachs’ Former HR Head Has Launched a Diversity and Inclusion Index

Eskalera, a technology startup led by Goldman Sachs former human resources head Dane Holmes, has launched an index to measure corporate diversity and inclusiveness,...

HSBC to Remove 35,000 Jobs Amidst Covid-19 Crises

HSBC Holdings Plc has restarted cutting as many as 35,000 jobs, three months after the coronavirus outbreak forced it to pause a long-awaited overhaul...

Genpact Offers Its Internal Skill Training Program Globally for Everyone

Genpact has announced Adapt and Rise, a role-based online learning platform that leverages Genpact's expertise honed from delivering real-world change for hundreds of clients....

San-Francisco Based Learning Platform Degreed Has Raised $32 Million in New Funding

The upskilling platform, Degreed, has announced $32 million in new funding in direct response to overwhelming demand for better skill insights, talent mobility, and...

Research Shows the Implications of Workplace Layouts on Employee Productivity and Overall Performance

As some workplaces prepare for the gradual return of employees and overhaul office layouts and seating plans, research has shown this could also have...

Employee Concierge ‘Back Technologies’ Integrates Automation Into Internal HR and Other Support Tasks

Companies are under increasing pressure to automate workflows and digitally service their employees, particularly in light of trends toward remote work. It takes an...

HR Strategies to Help Your Business Navigate the New ‘Normal’

No business is immune to the massive changes resulting from the health crisis. Organizations have proven themselves to be agile, and employees have demonstrated...

The Importance Of Diversity And Inclusion In HR, Hiring, Talent Management: Thoughts From A Top Expert

Michael C. Hyter is one of today’s best-known experts on inclusion and diversity and the author of The Power of Choice: Embracing Efficacy to Drive Your Career and The...

HR Expert Highlights Actionable Steps to ‘Make Real Change’ Against Racism in Your Workplace

Kyra Leigh Sutton, Ph.D., is a faculty member at the Rutgers University School of Management and Labor Relations, where she teaches human resources courses...

Adidas Employees Want Company to Investigate HR Chief for Response to Racial Issues

A group of Adidas employees from around the globe is asking the company to investigate its chief human resources officer, as part of a...